$CLRB
Cellectar Biosciences, Inc.

2013 Q3 Form 10-Q Financial Statement

#000114420413044768 Filed on August 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $840.0K $1.070M $900.0K
YoY Change 5.0% 18.89% 13.92%
% of Gross Profit
Research & Development $2.067M $1.649M $1.315M
YoY Change 64.94% 25.42% 35.53%
% of Gross Profit
Depreciation & Amortization $110.0K $110.0K $130.0K
YoY Change 0.0% -15.38% -13.33%
% of Gross Profit
Operating Expenses $2.067M $1.649M $1.315M
YoY Change 64.94% 25.42% -24.88%
Operating Profit -$2.910M -$2.723M -$2.212M
YoY Change 41.7% 23.11%
Interest Expense -$2.241K -$2.216K -$2.073K
YoY Change 6.92% 6.9% -99.39%
% of Operating Profit
Other Income/Expense, Net $1.595M $658.1K -$19.31K
YoY Change 88223.98% -3508.74%
Pretax Income -$1.320M -$2.060M -$2.230M
YoY Change -35.61% -7.62% -14.23%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.315M -$2.064M -$2.231M
YoY Change -35.91% -7.46% -14.2%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$44.00M -$68.67M -$111.5M
COMMON SHARES
Basic Shares Outstanding 57.40M shares 37.57M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.110M $5.830M $7.150M
YoY Change -8.75% -18.46% 116.01%
Cash & Equivalents $5.110M $5.828M $7.146M
Short-Term Investments
Other Short-Term Assets $390.0K $210.0K $200.0K
YoY Change -2.5% 5.0% 25.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.495M $6.031M $7.340M
YoY Change -8.27% -17.84% 110.92%
LONG-TERM ASSETS
Property, Plant & Equipment $2.450M $2.513M $2.810M
YoY Change -9.27% -10.55% -13.54%
Goodwill $1.675M $1.675M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $27.22K $27.22K $30.00K
YoY Change -9.26% -9.26% 0.0%
Total Long-Term Assets $4.152M $6.094M $4.510M
YoY Change -5.63% 35.13% -8.89%
TOTAL ASSETS
Total Short-Term Assets $5.495M $6.031M $7.340M
Total Long-Term Assets $4.152M $6.094M $4.510M
Total Assets $9.647M $12.13M $11.85M
YoY Change -7.15% 2.32% 40.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.160M $1.020M $610.0K
YoY Change 63.38% 67.21% 64.86%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change
Total Short-Term Liabilities $4.629M $6.091M $640.0K
YoY Change 525.56% 851.7% 42.22%
LONG-TERM LIABILITIES
Long-Term Debt $450.0K $450.0K $450.0K
YoY Change 0.0% 0.0% -2.17%
Other Long-Term Liabilities $140.0K $140.0K $130.0K
YoY Change 7.69% 7.69% 8.33%
Total Long-Term Liabilities $591.9K $590.2K $580.0K
YoY Change 2.04% 1.76% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.629M $6.091M $640.0K
Total Long-Term Liabilities $591.9K $590.2K $580.0K
Total Liabilities $5.221M $6.681M $1.220M
YoY Change 295.53% 447.63% 19.61%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $574.00 $574.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.426M $5.444M $10.63M
YoY Change
Total Liabilities & Shareholders Equity $9.647M $12.13M $11.85M
YoY Change -7.15% 2.32% 40.57%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$1.315M -$2.064M -$2.231M
YoY Change -35.91% -7.46% -14.2%
Depreciation, Depletion And Amortization $110.0K $110.0K $130.0K
YoY Change 0.0% -15.38% -13.33%
Cash From Operating Activities -$2.560M -$2.030M -$1.500M
YoY Change 51.48% 35.33% -41.86%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K $0.00 -$10.00K
YoY Change 300.0% -100.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities $1.880M $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $1.840M $0.00 -$10.00K
YoY Change -18500.0% -100.0% -100.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -10.00K 4.870M
YoY Change -100.0% -100.21% 15.68%
NET CHANGE
Cash From Operating Activities -2.560M -2.030M -1.500M
Cash From Investing Activities 1.840M 0.000 -10.00K
Cash From Financing Activities 0.000 -10.00K 4.870M
Net Change In Cash -720.0K -2.040M 3.360M
YoY Change -53.55% -160.71% 11.63%
FREE CASH FLOW
Cash From Operating Activities -$2.560M -$2.030M -$1.500M
Capital Expenditures -$40.00K $0.00 -$10.00K
Free Cash Flow -$2.520M -$2.030M -$1.490M
YoY Change 50.0% 36.24% -41.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
450000 USD
CY2013Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
139795 USD
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
135404 USD
CY2013Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
431 USD
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
1694 USD
CY2013Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
590226 USD
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
587098 USD
CY2013Q2 us-gaap Liabilities
Liabilities
6681102 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1319789 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
dei Trading Symbol
TradingSymbol
NVLT
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
57397997 shares
dei Entity Registrant Name
EntityRegistrantName
NOVELOS THERAPEUTICS, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001279704
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
55000 USD
CY2012Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
55000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
147369 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
327393 USD
CY2013Q2 nvlt Deferred Financing
DeferredFinancing
0 USD
CY2012Q4 nvlt Deferred Financing
DeferredFinancing
70539 USD
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1878232 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2000000 USD
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5828253 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4677545 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2013Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1021474 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
716990 USD
CY2013Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5066920 USD
CY2012Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
13304 USD
CY2013Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2482 USD
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2397 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6090876 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
732691 USD
dei Document Type
DocumentType
10-Q
CY2013Q2 us-gaap Assets Current
AssetsCurrent
6030622 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
5130477 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1073749 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15490162 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1314623 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29167175 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2211504 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3239450 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
5443935 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12125037 USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
574 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51239102 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4537489 USD
CY2012Q4 us-gaap Goodwill
Goodwill
1675462 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5161961 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
464 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
50435311 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
10158375 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11478164 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1648838 USD
CY2013Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
660341 USD
CY2012Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-17234 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2513499 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2645003 USD
CY2013Q2 us-gaap Goodwill
Goodwill
1675462 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27222 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27222 USD
CY2013Q2 us-gaap Assets
Assets
12125037 USD
CY2012Q4 us-gaap Assets
Assets
11478164 USD
CY2013Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
450000 USD
CY2013Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
45795741 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
40277400 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2642937 USD
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
896881 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2195452 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1894552 USD
CY2013Q2 us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
0 USD
CY2012Q2 us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
0 USD
us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
0 USD
us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
0 USD
us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
799133 USD
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
2722587 USD
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
2211504 USD
us-gaap Costs And Expenses
CostsAndExpenses
5434902 USD
us-gaap Costs And Expenses
CostsAndExpenses
4537489 USD
us-gaap Costs And Expenses
CostsAndExpenses
45456470 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2722587 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5434902 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-45456470 USD
CY2013Q2 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
CY2012Q2 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
us-gaap Revenue From Grants
RevenueFromGrants
0 USD
us-gaap Revenue From Grants
RevenueFromGrants
0 USD
us-gaap Revenue From Grants
RevenueFromGrants
244479 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
666384 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-46080 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
620372 USD
CY2013Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2012Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-744957 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-744957 USD
CY2013Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2216 USD
CY2012Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2073 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4866 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4145 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-460326 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1161 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
658125 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19307 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-83439 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-50225 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-339271 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2064462 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-2230811 USD
us-gaap Net Income Loss
NetIncomeLoss
-5518341 USD
us-gaap Net Income Loss
NetIncomeLoss
-4587714 USD
us-gaap Net Income Loss
NetIncomeLoss
-45795741 USD
CY2013Q2 nvlt Deemed Dividend On Warrants
DeemedDividendOnWarrants
0 USD
CY2012Q2 nvlt Deemed Dividend On Warrants
DeemedDividendOnWarrants
0 USD
nvlt Deemed Dividend On Warrants
DeemedDividendOnWarrants
0 USD
nvlt Deemed Dividend On Warrants
DeemedDividendOnWarrants
0 USD
nvlt Deemed Dividend On Warrants
DeemedDividendOnWarrants
-543359 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2064462 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2230811 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5518341 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4587714 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46339100 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.91
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57397997 shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38598586 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54359323 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37754402 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15917857 shares
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
219968 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
266077 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3133259 USD
us-gaap Share Based Compensation
ShareBasedCompensation
803791 USD
us-gaap Share Based Compensation
ShareBasedCompensation
823475 USD
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
0 USD
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
0 USD
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
-471765 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
89520 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
19671 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4513 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-40990 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-180024 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-115977 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
131199 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
304484 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
129831 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
641345 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
463722 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
4391 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
5974 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
139795 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3922597 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3200300 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35640327 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
905649 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92977 USD
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
0 USD
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
5500730 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-121768 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1933232 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5500730 USD
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29140 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5677260 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19671 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28791 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29140 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6717514 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2720985 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1677945 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1227944 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1178 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1098 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
8061 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4975153 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4870978 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43688181 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1338300 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
31667 USD
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 USD
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 USD
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
145 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
70539 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
28500 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5044514 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4869880 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48186094 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1150708 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1640440 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5828253 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5505960 USD
CY2002Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7146400 USD
nvlt Fair Value Of Warrants Classified As Derivative Liability
FairValueOfWarrantsClassifiedAsDerivativeLiability
5720000 USD
nvlt Fair Value Of Warrants Classified As Derivative Liability
FairValueOfWarrantsClassifiedAsDerivativeLiability
0 USD
nvlt Fair Value Of Warrants Classified As Derivative Liability
FairValueOfWarrantsClassifiedAsDerivativeLiability
5720000 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
43855 USD
us-gaap Interest Paid
InterestPaid
208689 USD
nvlt Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
0 USD
nvlt Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
0 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
nvlt Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
92194 USD
nvlt Issuance Of Common Stock In Exchange For Convertible Notes
IssuanceOfCommonStockInExchangeForConvertibleNotes
0 USD
nvlt Issuance Of Common Stock In Exchange For Convertible Notes
IssuanceOfCommonStockInExchangeForConvertibleNotes
0 USD
nvlt Issuance Of Common Stock In Exchange For Convertible Notes
IssuanceOfCommonStockInExchangeForConvertibleNotes
3184707 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
78408 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
439616 USD
nvlt Supplemental Goodwill
SupplementalGoodwill
0 USD
nvlt Supplemental Goodwill
SupplementalGoodwill
0 USD
nvlt Supplemental Goodwill
SupplementalGoodwill
1675462 USD
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57397997 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46397997 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57397997 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46397997 shares
CY2013Q2 nvlt Long Term Restricted Asset
LongTermRestrictedAsset
1878000 USD
nvlt Estimated Cost Of Construction Towards Manufacturing Facility
EstimatedCostOfConstructionTowardsManufacturingFacility
3000000 USD
CY2013Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
55000 USD
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
16527310 shares
CY2012Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
27310 shares
CY2013Q1 nvlt Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
770000 shares
nvlt Cash Fee Paid To Placement Agent
CashFeePaidToPlacementAgent
385000 USD
CY2013Q1 nvlt Warrants Exercise Price
WarrantsExercisePrice
0.625
CY2013Q1 nvlt Warrants Expiration Date
WarrantsExpirationDate
2018-02-04
CY2013Q1 nvlt Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
2000000 shares
CY2013Q1 nvlt Warrants Exercise Price
WarrantsExercisePrice
1.00
nvlt Change In Unrealized Gain Loss On Fair Value
ChangeInUnrealizedGainLossOnFairValue
660000 USD
CY2013Q2 nvlt Number Of Shares Issuable Upon Exercise Of Outstanding Warrants
NumberOfSharesIssuableUponExerciseOfOutstandingWarrants
36782459 shares
nvlt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedCompensationCost
1911165 USD
nvlt Employee Service Share Based Compensation Nonvested Total Compensation In Current Year
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInCurrentYear
629767 USD
nvlt Employee Service Share Based Compensation Nonvested Total Compensation In Year Two
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearTwo
872296 USD
nvlt Employee Service Share Based Compensation Nonvested Total Compensation In Year Three
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearThree
359254 USD
nvlt Employee Service Share Based Compensation Nonvested Total Compensation In Year Four
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearFour
49848 USD
CY2013Q2 nvlt Share Based Compensation Arrangement By Sharebased Payment Award Options Unvested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedAndExpectedToVestOutstandingNumber
2873634 shares
CY2013Q2 nvlt Weighted Average Grant Date Fair Value Of Vested Options Outstanding
WeightedAverageGrantDateFairValueOfVestedOptionsOutstanding
0.95
CY2013Q2 nvlt Weighted Average Grant Date Fair Value Of Unvested Options Outstanding
WeightedAverageGrantDateFairValueOfUnvestedOptionsOutstanding
0.71
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
377893 USD
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
406122 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.09 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.00915 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.61
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6439188 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
20000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
167550 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3418004 shares
CY2013Q2 nvlt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Unvested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsUnvestedOutstandingNumber
2873634 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3418004 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.52
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.74
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.75
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.12
CY2013Q2 nvlt Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedExercisableWeightedAverageExercisePrice
0.86
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.12
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y1M20D
nvlt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm
P8Y9M25D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M20D
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8068 USD
CY2013Q2 nvlt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingAggregateIntrinsicValue
6432 USD
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8068 USD
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6291638 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6291638 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.54
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.54
CY2013Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
62500 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
125000 USD
nvlt Payment Towards Clinical Trial Agreements
PaymentTowardsClinicalTrialAgreements
73385 USD
CY2013Q2 nvlt Payment Towards Clinical Trial Agreements
PaymentTowardsClinicalTrialAgreements
73385 USD
CY2013Q3 nvlt Payable To Retention Agreements
PayableToRetentionAgreements
392000 USD
CY2013Q3 nvlt Payment Upon Completion Of Certain Milestones
PaymentUponCompletionOfCertainMilestones
150000 USD
CY2013Q3 nvlt Paymant Of Lump Sum Amount Related To Employment Agreement
PaymantOfLumpSumAmountRelatedToEmploymentAgreement
150000 USD

Files In Submission

Name View Source Status
0001144204-13-044768-index-headers.html Edgar Link pending
0001144204-13-044768-index.html Edgar Link pending
0001144204-13-044768.txt Edgar Link pending
0001144204-13-044768-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
nvlt-20130630.xml Edgar Link completed
nvlt-20130630.xsd Edgar Link pending
nvlt-20130630_cal.xml Edgar Link unprocessable
nvlt-20130630_def.xml Edgar Link unprocessable
nvlt-20130630_lab.xml Edgar Link unprocessable
nvlt-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
v350595_10q.htm Edgar Link pending
v350595_ex31-1.htm Edgar Link pending
v350595_ex31-2.htm Edgar Link pending
v350595_ex32-1.htm Edgar Link pending